| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 05/16/2013 | US20130121953 Compositions |
| 05/16/2013 | US20130121929 Polyol and Polyether Iron Oxide Complexes as Pharmacological and/or MRI Contrast Agents |
| 05/16/2013 | US20130121917 Lipid-Peptide-Polymer Conjugates and Nanoparticles Thereof |
| 05/16/2013 | US20130121915 Protease-activatable pore-forming polypeptides |
| 05/16/2013 | US20130121913 Anti-CD19 Antibodies |
| 05/16/2013 | CA2855347A1 In-situ cross-linkable polymeric compositions and methods thereof |
| 05/16/2013 | CA2854934A1 Carrier molecule comprising a spr0096 and a spr2021 antigen |
| 05/16/2013 | CA2854817A1 Combination therapies using anti-pseudomonas psl and pcrv binding molecules |
| 05/16/2013 | CA2854720A1 Antibodies specific for trop-2 and their uses |
| 05/16/2013 | CA2853013A1 Composition for the photodynamic diagnosis and treatment of tumours |
| 05/15/2013 | EP2592146A2 Methods and compositions for treating prostate cancer |
| 05/15/2013 | EP2592103A1 Polymer aldehyde derivatives |
| 05/15/2013 | EP2591806A1 Medicinal composition |
| 05/15/2013 | EP2591804A2 Polymer nanoparticles coated by magnetic metal oxide and uses thereof |
| 05/15/2013 | EP2591803A1 Composition for the photodynamic diagnosis and treatment of tumours |
| 05/15/2013 | EP2591801A1 Nanoparticle compositions for generation of regulatory T cells and treatment of autoimmune diseases and other chronic inflammatory conditions |
| 05/15/2013 | EP2591792A1 Composition for nucleic acid delivery, carrier composition, pharmaceutical composition using the composition for nucleic acid delivery or the carrier composition, and method for delivering nucleic acid |
| 05/15/2013 | EP2591781A1 Particle coating preparation |
| 05/15/2013 | EP2591774A1 Orally disintegrating tablet |
| 05/15/2013 | EP2591771A1 Preservation of bioactive materials by freeze dried foam |
| 05/15/2013 | EP2591769A2 Compounds, compositions, kits and methods of use to topically treat acne and other skin conditions by administering a 19-nor containing vitamin D analog. |
| 05/15/2013 | EP2591768A1 Single unit dosage formulations of sevelamer and fat soluble vitamins and surface active agents |
| 05/15/2013 | EP2591009A1 Nitric oxide delivering hydroxyalkyl starch derivatives |
| 05/15/2013 | EP2591008A1 Conjugates comprising hydroxyalkyl starch and a cytotoxic agent and process for their preparation |
| 05/15/2013 | EP2591006A1 Processable single chain molecules and polypeptides made using same |
| 05/15/2013 | EP2590714A1 Dry compositions and devices containing such dry compositions for use in photodynamic therapy or photodynamic diagnosis |
| 05/15/2013 | EP2590682A1 Delivery of hydrophilic peptides |
| 05/15/2013 | EP2590681A1 Conjugates comprising hydroxyalkyl starch and a cytotoxic agent and process for their preparation |
| 05/15/2013 | EP2590680A1 Conjugates comprising hydroxyalkyl starch and a cytotoxic agent and process for their preparation |
| 05/15/2013 | EP2590679A1 Immunomodulatory protein constructs with a helical polymeric backbone |
| 05/15/2013 | EP2590678A1 Conjugates comprising hydroxyalkyl starch and a cytotoxic agent and process for their preparation |
| 05/15/2013 | EP2590677A1 Conjugates comprising hydroxyalkyl starch and a cytotoxic agent and process for their preparation |
| 05/15/2013 | EP2590675A1 Respiratory syncytial virus antigenic compositions and methods |
| 05/15/2013 | EP2590674A2 Compositions and methods for treating influenza |
| 05/15/2013 | EP2590652A1 Pharmaceutical compositions containing vanoxerine |
| 05/15/2013 | EP2590634A2 Combination immediate/delayed release delivery system for short half-life pharmaceuticals including remogliflozin |
| 05/15/2013 | EP2590629A2 Biodegradable phase separated segmented multi block co-polymers and release of biologically active polypeptides |
| 05/15/2013 | EP2590620A1 Stable aqueous formulations comprising poorly water soluble active ingredients |
| 05/15/2013 | CN1984679B Methods for preparing immunogenic conjugates |
| 05/15/2013 | CN1972717B Binary thermo-gelling composition |
| 05/15/2013 | CN103108658A Antibody formulations |
| 05/15/2013 | CN103108643A Antimicrobial agents and methods of use |
| 05/15/2013 | CN103108635A Liquid formulations of rupatadine fumarate |
| 05/15/2013 | CN103108628A Formulations for infusion of type B lantibiotics |
| 05/15/2013 | CN103108627A Pharmaceutical depot for 5-fluoro-2 [ [ (1s) -1- (5-fluoro-2-pyridyl)ethyl]amino]-6-[(5-isopropoxy-1h-pyrazol-3-yl)amino]pyridine-3-carbonitrile |
| 05/15/2013 | CN103108625A Parenteral formulations of elacytarabine derivatives |
| 05/15/2013 | CN103108623A Composition for the treatment of superficial lesions |
| 05/15/2013 | CN103102479A Reduction sensitive fluorescent nano micelle with FRET (Fluorescence Resonance Energy Transfer) effect and preparation method thereof |
| 05/15/2013 | CN103102445A PH (Potential of Hydrogen) independent polymethacrylate and preparation method thereof |
| 05/15/2013 | CN103102418A Fusion protein of granulocyte colony-stimulating factor (G-CSF) as well as mutant of granulocyte colony-stimulating factor (mG-CSF) and human serum albumin 3rd domain (3DHSA) and application |
| 05/15/2013 | CN103102416A Recombinant fusion protein of IL3 and Lidamycin, preparation method and application thereof |
| 05/15/2013 | CN103102406A Continuation - site directed modification of FVIII ? |
| 05/15/2013 | CN103100093A Load small interfering RNA nanoscale lipid microbubble ultrasonic contrast agent and preparation method |
| 05/15/2013 | CN103100091A Compound seaweed gum and application thereof to capsule preparation |
| 05/15/2013 | CN103100090A Hard capsule shell material and production process thereof |
| 05/15/2013 | CN103100089A Oral pH responsive intestinal targeting vector as well as preparation method and applications thereof |
| 05/15/2013 | CN103100088A Macromolecule skin penetration enhancer as well as preparation method and applications thereof |
| 05/15/2013 | CN103100087A Method for preparing calcium phosphate/organic matter composite nanoparticles |
| 05/15/2013 | CN103100086A Water-soluble carrier |
| 05/15/2013 | CN103099938A Jiuhua plaster |
| 05/15/2013 | CN103099873A Green coffee bean extract sustained-release tablet and preparation method thereof |
| 05/15/2013 | CN103099836A Process for preparing lipid-diluting soft capsules |
| 05/15/2013 | CN103099825A Novel cordyceps sinensis capsule and preparation method thereof |
| 05/15/2013 | CN103099821A High-dose bacillus licheniformis viable bacterium composition as well as preparation method and application thereof |
| 05/15/2013 | CN103099820A Streptococcus mutans infection and cariogenic animal model establishing method |
| 05/15/2013 | CN103099807A Compound zinc gluconate and ibuprofen oral-administration composition for covering bitter taste and improving ibuprofen dissolution |
| 05/15/2013 | CN103099800A External-use and oral-use composition comprising tranexamic acid |
| 05/15/2013 | CN103099799A Composite film-like preparation and preparation method thereof |
| 05/15/2013 | CN103099798A Preparation method of soybean isoflavone-chitosan slow-release microcapsules |
| 05/15/2013 | CN103099797A Propylene glycol mannate sulfate capsule and its preparation method |
| 05/15/2013 | CN103099796A Propylene glycol marinate sulfate-containing sustained-release preparation and preparation method thereof |
| 05/15/2013 | CN103099795A Indometacin sustained release tablet, preparation method thereof, as well as release controlling method and standard |
| 05/15/2013 | CN103099794A Vitamin C clathrate dispersible tablet |
| 05/15/2013 | CN103099793A Tablet and preparation method |
| 05/15/2013 | CN103099792A Preparation method of IV crystal linezolid tablets having high drug loading capacity and capable of quickly dissolving |
| 05/15/2013 | CN103099791A Oral composition of meloxicam capable of increasing dissolution rate |
| 05/15/2013 | CN103099790A Tablet containing everolimus and preparation method thereof |
| 05/15/2013 | CN103099789A Preparation method of vitamin C granules |
| 05/15/2013 | CN103099787A Vitamin C dry suspension |
| 05/15/2013 | CN103099786A Preparation method of micro/nanofiber sustained release preparation |
| 05/15/2013 | CN103099785A Method for preparing hydrophobic medicament nuclear shell granule-type solid dispersion by static electricity spraying method |
| 05/15/2013 | CN103099784A Nanometer medicine particle, preparation method and application thereof |
| 05/15/2013 | CN103099783A Transdermal delivery nano-preparation, and preparation method and application thereof |
| 05/15/2013 | CN103099782A Core-shell type nano medical granule, preparation method and application thereof |
| 05/15/2013 | CN103099781A Liposome, a pharmaceutical composition comprising the liposome, and a method of delivering active agents to a target site using the liposome |
| 05/15/2013 | CN103099778A Exterior medicine composition of fluocinolone acetonide and ester of fluocinolone acetonide |
| 05/15/2013 | CN103099777A Bio-enzyme hydrogel taking porous calcium carbonate as carrier and preparation method of bio-enzyme hydrogel |
| 05/15/2013 | CN103099775A Adapalene gel |
| 05/15/2013 | CN103099210A Polygonum multiflorum nutrient tablet and making method thereof |
| 05/15/2013 | CN102671214B Camptothecin supramolecular micelle prodrug for reducing, degrading and releasing drugs and preparation method and application |
| 05/15/2013 | CN102641507B Preparation method for methotrexate/layered double hydroxide nanocomposite |
| 05/15/2013 | CN102614115B Sodium dichlorophenolate self-emulsifying ointment |
| 05/15/2013 | CN102552922B Drug combination and preparation method and application thereof |
| 05/15/2013 | CN102526744B Medicinal composition and preparation method and application thereof |
| 05/15/2013 | CN102429875B Cyclosporin A pulmonary inhaled macroporous microspheres and preparation method thereof |
| 05/15/2013 | CN102391504B Copolymer, glucose sensitive micelle, glucose sensitive medicine-carrying micelle and preparation method thereof |
| 05/15/2013 | CN102366412B Preparation method of tolvaptan tablet |
| 05/15/2013 | CN102309475B Levocarnitine for injection and preparation method thereof |
| 05/15/2013 | CN102302519B Propolis nano-emulsion and preparation method thereof |
| 05/15/2013 | CN102302475B Resibufogenin dry powder inhalant and preparation method and application thereof |